Industry / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
COINFAR Looks To Harness Nature
March 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity. The support will be offered to companies and institutes that submit research proposals and should provide a vital cash-line for Brazil's fledgling biotech